Hex Trust Expands Custody and Trading Services to Injective Ecosystem
Nov 14, 2024

Hex Trust Expands Custody and Trading Services to Injective Ecosystem

HONG KONG, November 14, 2024 - Hex Trust officially joined the Injective blockchain as a validator in February 2024 and is now expanding its range of products, including custody, staking, and trading services for institutional Injective users. Since becoming a validator, Hex Trust has experienced a rapid influx of delegation, with over 1.5 million $INJ tokens currently delegated, representing over 2% of the voting power of the Injective blockchain.

What is Injective?

Injective is a high-speed, interoperable layer one blockchain designed for financial applications, offering a robust infrastructure for developers to build decentralized applications (dApps). Its unique plug-and-play modules facilitate the creation of innovative financial products, making it an ideal partner for Hex Trust. The native asset, $INJ, fuels its expanding ecosystem, which is supported by major industry players including Binance and prominent investors like Jump Crypto and Pantera.

Hex Trust’s Role in the Injective Ecosystem

By becoming a validator, Hex Trust contributes to the security and decentralization of the Injective network and strengthens its global validator set. The delegation of millions of $INJ highlights the trust both institutional investors place in Hex Trust's ability to manage and secure assets on the network. Hex Trust also has an active platform in the over-the-counter (OTC) trading space, allowing institutional investors to trade without minimal slippage and price movement. In turn, this platform allows for efficient trade settlement across a wide range of trading strategies.

Institutional-Grade Custody and Staking

For institutional investors, Hex Trust offers a seamless and secure way to participate in the Injective ecosystem. With its custody services, investors can stake $INJ within a fully compliant framework, benefitting from both the financial rewards of staking and the assurance of top-tier asset protection.

Hex Trust’s expanding role as a validator signals a broader trend of institutional involvement in decentralized finance and blockchain networks. As the demand for secure, compliant, and scalable solutions grows, Hex Trust will continue to be a key player in driving institutional adoption of blockchain technologies.

With over 1.5 million $INJ delegated and a robust suite of institutional tools, Hex Trust is well-positioned to play an increasingly important role in the Injective ecosystem. As the Web3 space evolves, Hex Trust and Injective align missions to bring the traditional finance and decentralized finance worlds even closer together. 

***

About Hex Trust

Established in 2018, Hex Trust offers regulated institutional digital asset Custody, Staking and Markets services to builders, investors and service providers. Get access to our comprehensive, secure and regulated suite of services built on our proprietary and fully integrated infrastructure.

Hex Trust, already licensed in Dubai and Hong Kong and registered in France and Italy, has recently obtained in-principle approval from the Monetary Authority of Singapore for a Major Payment Institution License.

For more information, visit hextrust.com or follow Hex Trust on LinkedIn, X and Telegram.

About Injective

Injective is a lightning fast interoperable layer one blockchain optimized for building the premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps. INJ is the native asset that powers Injective and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by prominent investors such as Jump Crypto, Pantera and Mark Cuban.

Website | Telegram | Discord | Blog | Twitter | Youtube | Facebook | LinkedIn | Reddit | Instagram | Orbit Newsletter

Disclaimer:  This post is for informational purposes only and is not financial or investment advice, or an endorsement of any project or service.  As always, users should do their own research. The information contained in this article is intended to be current at the time of publication, but may not remain so indefinitely.

Thank you! Your submission has been received!
Download the PDF ⟩
Oops! Something went wrong while submitting the form.
We use cookies, including third-party cookies, to ensure that we give you the best experience on our website. By continuing to browse, you consent to the use of cookies. Learn more about cookies and how to control whether they are enabled. View our Privacy Policy for more information.
Cookie preferences